NEW YORK / RankWire.AI / – On Wednesday, U.S. equities moved higher, buoyed by a notable decline in long-term Treasury yields and a boost from healthcare sector gains. The S&P 500 increased by 16.22 points, or 0.21%, closing at 7,707.98. The Dow Jones Industrial Average gained 119.65 points, or 0.22%, ending the day at 53,463.05. The Nasdaq Composite also advanced, adding 41.38 points, or 0.16%, to finish at 26,331.09. This upward movement marked the end of a three-session losing streak for all three major U.S. indices.
Much of the day’s trading momentum was driven by bond market activity following the U.S. Treasury Department’s announcement of increased liquidity support buybacks for longer-term debt. Beginning September 9, the maximum purchase size will increase to at least $4 billion per operation, up from $2 billion. This applies to nominal coupon securities with maturities in the 10-to-20-year and 20-to-30-year ranges. The department indicated that these larger purchases will continue through November 4 and are a response to strong demand for high-quality offers.
Following the announcement, Treasury yields declined as bond prices moved upward. The benchmark 10-year yield fell to approximately 4.65%, while the 30-year yield decreased to around 5.20%. Notably, the 30-year yield had reached 5.337% on Tuesday, its highest level since 2007. The decline in yields eased some of the pressure exerted by rising borrowing costs on equities, contributing to Wall Street’s recovery from earlier-week losses.
Healthcare Sector’s Gains Boost Market Confidence
The healthcare sector lifted the market after Moderna and Merck announced encouraging late-stage trial results for melanoma treatment. Moderna’s shares surged 177%, while Merck’s stock increased by 12.6% during the trading session. The Phase 3 INTerpath-001 trial evaluated intismeran autogene combined with Keytruda following surgery for patients with high-risk melanoma. The trial successfully met its primary endpoint of recurrence-free survival, as well as a key secondary endpoint measuring survival without cancer spreading to distant parts of the body.
Meanwhile, consumer stocks also experienced gains amid strong quarterly earnings reports from several major firms. Estée Lauder’s shares jumped over 16% after earnings were released, with Target and Lowe’s also seeing increases following their latest financial disclosures. Smaller-cap stocks outperformed the large-cap indexes, with the Russell 2000 advancing roughly 0.5%. These movements helped extend the market’s recovery beyond the healthcare sector. Technology shares showed mixed performance, which limited the overall gains in major indices.
Week-to-Date Performance Shows Slight Overall Decline
Despite Wednesday’s upward move, the three main U.S. stock indexes remained in the red for the week through the close. The S&P 500 was approximately 1% below its level from the previous Friday, while the Dow declined about 0.5% over the same period. The Nasdaq had fallen roughly 1.5%. The rebound followed several sessions where rising long-term yields negatively impacted stock valuations, prompting a more cautious approach among investors across major sectors.
By the close on Wednesday, the major averages remained firmly positive for 2026, with the S&P 500 up about 12.6% since the start of the year. The Dow had gained roughly 11.2%, and the Nasdaq increased around 13.3%. The day’s gains reflected a modest rebound on Wall Street, driven by declining Treasury yields and strong performances in healthcare stocks. The U.S. Treasury Department’s buyback plan and positive results from the melanoma trial emerged as some of the clearest market catalysts throughout the trading session.